Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2020 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2020 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

lncRNA MIAT increases cell viability, migration, EMT and ECM production in age‑related cataracts by regulating the miR‑181a/CTGF/ERK signaling pathway

  • Authors:
    • Jiaojiao Ling
    • Ke Tan
    • Lu Lu
    • Fang Yang
    • Lan Luan
  • View Affiliations / Copyright

    Affiliations: Department of Ophthalmology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China
    Copyright: © Ling et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1053-1063
    |
    Published online on: May 13, 2020
       https://doi.org/10.3892/etm.2020.8749
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Age-related cataract (ARC) is a common cause of blindness in elderly individuals. Long non‑coding RNA (lncRNA) myocardial infarction associated transcript (MIAT) has been reported to participate in various biological processes in a number of diseases; however, the biological mechanism underlying MIAT during ARC is not completely understood. The expression levels of MIAT, microRNA (miR)‑181a and connective tissue growth factor (CTGF) were measured by reverse transcription‑quantitative PCR. The protein expression levels of CTGF, α‑smooth muscle actin, fibronectin, collagen type I, ERK, phosphorylated (p)‑ERK, mitogen‑activated protein kinase (MEK), and p‑MEK were detected by western blotting. Cell viability and migration were assessed using MTT and Transwell assays, respectively. Moreover, a dual‑luciferase reporter assay was performed to investigate the interaction between miR‑181a and MIAT or CTGF. MIAT and CTGF were upregulated, while miR‑181a was significantly downregulated in ARC tissues compared with normal tissues. MIAT or CTGF knockdown decreased cell viability, migration, epithelial‑mesenchymal transition and extracellular matrix production in TGF‑β2‑treated SRA01/04 cells. It was hypothesized that miR‑181a may be sponged by MIAT and may target CTGF. Furthermore, the miR‑181a inhibitor reversed the inhibitory effect of MIAT knockdown on the progression of TGF‑β2‑treated SRA01/04 cells. Moreover, CTGF knockdown also reversed MIAT overexpression‑mediated progression of TGF‑β2‑treated SRA01/04 cells. In addition, MIAT and CTGF regulated the activity of the ERK signaling pathway. The results suggested that MIAT may regulate the progression of ARC via the miR‑181a/CTGF/ERK signaling pathway, which may serve as a novel therapeutic target for ARC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Lim JC, Umapathy A and Donaldson PJ: Tools to fight the cataract epidemic: A review of experimental animal models that mimic age related nuclear cataract. Exp Eye Res. 145:432–443. 2016.PubMed/NCBI View Article : Google Scholar

2 

Raj SM, Vasavada AR, Johar SR and Vasavada VA and Vasavada VA: Post-operative capsular opacification: A review. Int J Biomed Sci. 3:237–250. 2007.PubMed/NCBI

3 

Peng Q, Hennig A, Vasavada AR and Apple DJ: Posterior capsular plaque: A common feature of cataract surgery in the developing world. Am J Ophthalmol. 125:621–626. 1998.PubMed/NCBI View Article : Google Scholar

4 

Lovicu FJ, Ang S, Chorazyczewska M and McAvoy JW: Deregulation of lens epithelial cell proliferation and differentiation during the development of TGFbeta-induced anterior subcapsular cataract. Dev Neurosci. 26:446–455. 2004.PubMed/NCBI View Article : Google Scholar

5 

Marcantonio JM, Syam PP, Liu CS and Duncan G: Epithelial transdifferentiation and cataract in the human lens. Exp Eye Res. 77:339–346. 2003.PubMed/NCBI View Article : Google Scholar

6 

Guo R, Meng Q, Guo H, Xiao L, Yang X, Cui Y and Huang Y: TGF-β2 induces epithelial-mesenchymal transition in cultured human lens epithelial cells through activation of the PI3K/Akt/mTOR signaling pathway. Mol Med Rep. 13:1105–1110. 2016.PubMed/NCBI View Article : Google Scholar

7 

Ma B, Kang Q, Qin L, Cui L and Pei C: TGF-β2 induces transdifferentiation and fibrosis in human lens epithelial cells via regulating gremlin and CTGF. Biochem Biophys Res Commun. 447:689–695. 2014.PubMed/NCBI View Article : Google Scholar

8 

Mathieu EL, Belhocine M, Dao LT, Puthier D and Spicuglia S: Functions of lncRNA in development and diseases. Med Sci (Paris). 30:790–796. 2014.PubMed/NCBI View Article : Google Scholar : (In French).

9 

Zhang Z, Zhu H, Liu Y, Quan F, Zhang X and Yu L: LncRNA HOTAIR mediates TGF-β2-induced cell growth and epithelial-mesenchymal transition in human lens epithelial cells. Acta Biochim Biophys Sin (Shanghai). 50:1028–1037. 2018.PubMed/NCBI View Article : Google Scholar

10 

Chen B, Ma J, Li C and Wang Y: Long noncoding RNA KCNQ1OT1 promotes proliferation and epithelial-mesenchymal transition by regulation of SMAD4 expression in lens epithelial cells. Mol Med Rep. 18:16–24. 2018.PubMed/NCBI View Article : Google Scholar

11 

Li G, Song H, Chen L, Yang W, Nan K and Lu P: TUG1 promotes lens epithelial cell apoptosis by regulating miR-421/caspase-3 axis in age-related cataract. Exp Cell Res. 356:20–27. 2017.PubMed/NCBI View Article : Google Scholar

12 

Wang Y, Chen L, Gu Y, Wang Y, Yuan Y, Zhu Q, Bi M and Gu S: LncRNA FEZF1-AS1 promotes TGF-β2-mediated proliferation and migration in human lens epithelial cells SRA01/04. J Ophthalmol. 2019(4736203)2019.PubMed/NCBI View Article : Google Scholar

13 

Gong W, Zhu G, Li J and Yang X: LncRNA MALAT1 promotes the apoptosis and oxidative stress of human lens epithelial cells via p38MAPK pathway in diabetic cataract. Diabetes Res Clin Pract. 144:314–321. 2018.PubMed/NCBI View Article : Google Scholar

14 

Qi D, Wang M, Zhang D and Li H: Tanshinone IIA protects lens epithelial cells from H2O2-induced injury by upregulation of lncRNA ANRIL. J Cell Physiol (Epub ahead of print).

15 

Cheng T, Xu M, Qin B, Wu J, Tu Y, Kang L, Wang Y and Guan H: lncRNA H19 contributes to oxidative damage repair in the early age-related cataract by regulating miR-29a/TDG axis. J Cell Mol Med. 23:6131–6139. 2019.PubMed/NCBI View Article : Google Scholar

16 

Toraih EA, El-Wazir A, Alghamdi SA, Alhazmi AS, El-Wazir M, Abdel-Daim MM and Fawzy MS: Association of long non-coding RNA MIAT and MALAT1 expression profiles in peripheral blood of coronary artery disease patients with previous cardiac events. Genet Mol Biol. 42:509–518. 2019.PubMed/NCBI View Article : Google Scholar

17 

Tan J, Liu S, Jiang Q, Yu T and Huang K: LncRNA-MIAT increased in patients with coronary atherosclerotic heart disease. Cardiol Res Pract. 2019(6280194)2019.PubMed/NCBI View Article : Google Scholar

18 

Zhu M, Li N, Luo P, Jing W, Wen X, Liang C and Tu J: Peripheral blood leukocyte expression of lncRNA MIAT and its diagnostic and prognostic value in ischemic stroke. J Stroke Cerebrovasc Dis. 27:326–337. 2018.PubMed/NCBI View Article : Google Scholar

19 

Shen Y, Dong LF, Zhou RM, Yao J, Song YC, Yang H, Jiang Q and Yan B: Role of long non-coding RNA MIAT in proliferation, apoptosis and migration of lens epithelial cells: A clinical and in vitro study. J Cell Mol Med. 20:537–548. 2016.PubMed/NCBI View Article : Google Scholar

20 

Korhan P, Erdal E and Atabey N: MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met. Biochem Biophys Res Commun. 450:1304–1312. 2014.PubMed/NCBI View Article : Google Scholar

21 

Gong W, Li J, Wang Y, Meng J and Zheng G: miR-221 promotes lens epithelial cells apoptosis through interacting with SIRT1 and E2F3. Chem Biol Interact. 306:39–46. 2019.PubMed/NCBI View Article : Google Scholar

22 

Dong N, Tang X and Xu B: miRNA-181a inhibits the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells. Invest Ophthalmol Vis Sci. 56:993–1001. 2015.PubMed/NCBI View Article : Google Scholar

23 

Ramazani Y, Knops N, Elmonem MA, Nguyen TQ, Arcolino FO, van den Heuvel L, Levtchenko E, Kuypers D and Goldschmeding R: Connective tissue growth factor (CTGF) from basics to clinics. Matrix Biol. 68-69:44–66. 2018.PubMed/NCBI View Article : Google Scholar

24 

Pei C, Ma B, Kang QY, Qin L and Cui LJ: Effects of transforming growth factor β2 and connective tissue growth factor on induction of epithelial mesenchymal transition and extracellular matrix synthesis in human lens epithelial cells. Int J Ophthalmol. 6:752–757. 2013.PubMed/NCBI View Article : Google Scholar

25 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

26 

Lv J, Sun B, Mai Z, Jiang M and Du J: CLDN-1 promoted the epithelial to migration and mesenchymal transition (EMT) in human bronchial epithelial cells via Notch pathway. Mol Cell Biochem. 432:91–98. 2017.PubMed/NCBI View Article : Google Scholar

27 

Ma B, Yang L, Jing R, Liu J, Quan Y, Hui Q, Li J, Qin L and Pei C: Effects of Interleukin-6 on posterior capsular opacification. Exp Eye Res. 172:94–103. 2018.PubMed/NCBI View Article : Google Scholar

28 

Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M and Epstein S: Age-related cataract. Lancet. 365:599–609. 2005.PubMed/NCBI View Article : Google Scholar

29 

Li Z, Qu L, Luo W, Tian Y, Zhai H, Xu K and Zhong H: Mig-6 is down-regulated in HCC and inhibits the proliferation of HCC cells via the P-ERK/Cyclin D1 pathway. Exp Mol Pathol. 102:492–499. 2017.PubMed/NCBI View Article : Google Scholar

30 

Li TF, Liu J and Fu SJ: The interaction of long non-coding RNA MIAT and miR-133 play a role in the proliferation and metastasis of pancreatic carcinoma. Biomed Pharmacother. 104:145–150. 2018.PubMed/NCBI View Article : Google Scholar

31 

Zhang C, Xie L, Liang H and Cui Y: LncRNA MIAT facilitates osteosarcoma progression by regulating miR-128-3p/VEGFC Axis. IUBMB Life. 71:845–853. 2019.PubMed/NCBI View Article : Google Scholar

32 

Esteller M: Non-coding RNAs in human disease. Nat Rev Genet. 12:861–874. 2011.PubMed/NCBI View Article : Google Scholar

33 

Jun JI and Lau LF: Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov. 10:945–963. 2011.PubMed/NCBI View Article : Google Scholar

34 

Hong L, Lai HL, Fang Y, Tao Y and Qiu Y: Silencing CTGF/CCN2 inactivates the MAPK signaling pathway to alleviate myocardial fibrosis and left ventricular hypertrophy in rats with dilated cardiomyopathy. J Cell Biochem. 119:9519–9531. 2018.PubMed/NCBI View Article : Google Scholar

35 

Liu F, Chen WW, Li Y, Zhang JQ and Zheng QB: MiR-6836-3p promotes proliferation of hypertrophic scar fibroblasts by targeting CTGF. Eur Rev Med Pharmacol Sci. 22:4069–4074. 2018.PubMed/NCBI View Article : Google Scholar

36 

Wang WB, Li HP, Yan J, Zhuang F, Bao M, Liu JT, Qi YX and Han Y: CTGF regulates cyclic stretch-induced vascular smooth muscle cell proliferation via microRNA-19b-3p. Exp Cell Res. 376:77–85. 2019.PubMed/NCBI View Article : Google Scholar

37 

Dai X, Song R and Xiong Y: The expression of ERK and JNK in patients with an endemic osteochondropathy, Kashin-Beck disease. Exp Cell Res. 359:337–341. 2017.PubMed/NCBI View Article : Google Scholar

38 

Zong D, Li J, Cai S, He S, Liu Q, Jiang J, Chen S, Long Y, Chen Y, Chen P and Ouyang R: Notch1 regulates endothelial apoptosis via the ERK pathway in chronic obstructive pulmonary disease. Am J Physiol Cell Physiol. 315:C330–C340. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ling J, Tan K, Lu L, Yang F and Luan L: lncRNA MIAT increases cell viability, migration, EMT and ECM production in age‑related cataracts by regulating the miR‑181a/CTGF/ERK signaling pathway. Exp Ther Med 20: 1053-1063, 2020.
APA
Ling, J., Tan, K., Lu, L., Yang, F., & Luan, L. (2020). lncRNA MIAT increases cell viability, migration, EMT and ECM production in age‑related cataracts by regulating the miR‑181a/CTGF/ERK signaling pathway. Experimental and Therapeutic Medicine, 20, 1053-1063. https://doi.org/10.3892/etm.2020.8749
MLA
Ling, J., Tan, K., Lu, L., Yang, F., Luan, L."lncRNA MIAT increases cell viability, migration, EMT and ECM production in age‑related cataracts by regulating the miR‑181a/CTGF/ERK signaling pathway". Experimental and Therapeutic Medicine 20.2 (2020): 1053-1063.
Chicago
Ling, J., Tan, K., Lu, L., Yang, F., Luan, L."lncRNA MIAT increases cell viability, migration, EMT and ECM production in age‑related cataracts by regulating the miR‑181a/CTGF/ERK signaling pathway". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1053-1063. https://doi.org/10.3892/etm.2020.8749
Copy and paste a formatted citation
x
Spandidos Publications style
Ling J, Tan K, Lu L, Yang F and Luan L: lncRNA MIAT increases cell viability, migration, EMT and ECM production in age‑related cataracts by regulating the miR‑181a/CTGF/ERK signaling pathway. Exp Ther Med 20: 1053-1063, 2020.
APA
Ling, J., Tan, K., Lu, L., Yang, F., & Luan, L. (2020). lncRNA MIAT increases cell viability, migration, EMT and ECM production in age‑related cataracts by regulating the miR‑181a/CTGF/ERK signaling pathway. Experimental and Therapeutic Medicine, 20, 1053-1063. https://doi.org/10.3892/etm.2020.8749
MLA
Ling, J., Tan, K., Lu, L., Yang, F., Luan, L."lncRNA MIAT increases cell viability, migration, EMT and ECM production in age‑related cataracts by regulating the miR‑181a/CTGF/ERK signaling pathway". Experimental and Therapeutic Medicine 20.2 (2020): 1053-1063.
Chicago
Ling, J., Tan, K., Lu, L., Yang, F., Luan, L."lncRNA MIAT increases cell viability, migration, EMT and ECM production in age‑related cataracts by regulating the miR‑181a/CTGF/ERK signaling pathway". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1053-1063. https://doi.org/10.3892/etm.2020.8749
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team